Mereo BioPharma Group PLC (MREO)
2.78
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 16:00
2.785
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Market Cap: 389.92M for April 24, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 24, 2024 | 389.92M |
| April 23, 2024 | 389.92M |
| April 22, 2024 | 391.32M |
| April 19, 2024 | 370.28M |
| April 18, 2024 | 371.68M |
| April 17, 2024 | 361.86M |
| April 16, 2024 | 377.29M |
| April 15, 2024 | 374.49M |
| April 12, 2024 | 381.50M |
| April 11, 2024 | 384.31M |
| April 10, 2024 | 412.36M |
| April 09, 2024 | 439.01M |
| April 08, 2024 | 444.62M |
| April 05, 2024 | 461.45M |
| April 04, 2024 | 457.24M |
| April 03, 2024 | 478.28M |
| April 02, 2024 | 474.07M |
| April 01, 2024 | 478.28M |
| March 28, 2024 | 462.85M |
| March 27, 2024 | 420.77M |
| March 26, 2024 | 413.76M |
| March 25, 2024 | 416.56M |
| March 22, 2024 | 417.97M |
| March 21, 2024 | 415.16M |
| March 20, 2024 | 434.80M |
| Date | Value |
|---|---|
| March 19, 2024 | 426.38M |
| March 18, 2024 | 433.40M |
| March 15, 2024 | 436.20M |
| March 14, 2024 | 440.41M |
| March 13, 2024 | 447.42M |
| March 12, 2024 | 490.90M |
| March 11, 2024 | 497.91M |
| March 08, 2024 | 502.12M |
| March 07, 2024 | 510.54M |
| March 06, 2024 | 523.16M |
| March 05, 2024 | 524.56M |
| March 04, 2024 | 541.39M |
| March 01, 2024 | 556.82M |
| February 29, 2024 | 532.98M |
| February 28, 2024 | 522.42M |
| February 27, 2024 | 542.03M |
| February 26, 2024 | 511.21M |
| February 23, 2024 | 515.42M |
| February 22, 2024 | 486.00M |
| February 21, 2024 | 495.81M |
| February 20, 2024 | 501.41M |
| February 16, 2024 | 519.62M |
| February 15, 2024 | 516.82M |
| February 14, 2024 | 508.41M |
| February 13, 2024 | 518.22M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
19.92M
Minimum
Mar 18 2020
567.24M
Maximum
Jan 29 2024
179.75M
Average
155.59M
Median
Mar 17 2022
Market Cap Benchmarks
| Adaptimmune Therapeutics PLC | 266.57M |
| Biodexa Pharmaceuticals Plc | 3.288M |
| NuCana PLC | 8.119M |
| TC BioPharm (Holdings) PLC | 4.697M |
| Autolus Therapeutics PLC | 1.120B |
Market Cap Related Metrics
| PS Ratio | 36.67 |
| Price to Book Value | 7.715 |
| Price | 2.78 |
| Earnings Yield | -7.19% |